Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

- PMLiVE

Missed Origins’ Webinar? Watch How Patient Experience Data is Changing Pharma!

We are thrilled to announce that the recording of our recent webinar, "Patient Data: From data to decisions, maximising the impact of patience experience data in pharma" is now available...

Origins – The Patient Focused Specialists

- PMLiVE

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

Cuttsy + Cuttsy

- PMLiVE

J&J’s Tecvayli recommended by NICE to treat relapsed and refractory multiple myeloma

Approximately 5,900 new cases of the blood cancer are diagnosed every year in the UK

- PMLiVE

Boehringer Ingelheim and Brainomix enter fibrosing lung disease partnership

Pulmonary fibrosis, a chronic lung condition, affects up to 20 out of every 100,000 people worldwide

- PMLiVE

LEO Pharma’s delgocitinib cream shows promise in phase 3 chronic hand eczema trials

About 70% of patients with severe cases of the condition report problems performing everyday activities

- PMLiVE

The omnichannel wonderland of opportunities

Picking your omnichannel direction requires a disciplined, scientific approach

- PMLiVE

Always Be in a Growth Mindset: Chief Strategy Officer Christina Hoffman’s Return to Her Education Roots

Medicine is always changing, and the career of Medscape Education’s Chief Strategy Officer, Christina Hoffman, is no exception. The 17-year Medscape veteran recently said goodbye to her role as leader...

Medscape Education

- PMLiVE

FDA establishes rare disease innovation hub to accelerate treatment development

More than 30 million people in the US are currently affected by a rare disease

- PMLiVE

NICE recommends Accord’s oral hormone therapy Orgovyx for advanced prostate cancer

The drug is now the first oral treatment of its kind to be approved by the agency

- PMLiVE

Sanofi/Sobi’s haemophilia A therapy shows ‘highly effective’ bleed protection in children

The rare bleeding disorder affects approximately one in every 5,000 male births annually

- PMLiVE

Experts issue call for new ‘toolbox’ to simplify early-phase clinical trial regulation in UK

The article outlines several recommendations to help improve early-phase clinical trials

- PMLiVE

Women in pharma

Iona Everson from PMGroup spoke to Doina Ionescu, managing director for the UK and Ireland at Merck, about her professional journey and experiences as a woman in the industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links